Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Public Health Action Plan to Combat Antimicrobial Resistance

2012 Action Plan [PDF - 24 pages 334 KB]

Overview of the Action Plan

Rationale for Action Plan

The Action Plan is a blueprint for specific, coordinated, federal actions to address the growing threat of antimicrobial resistance in the United States. In the Action Plan, the Interagency Task Force on Antimicrobial Resistance (ITFAR) addresses the three areas of federal action: surveillance, prevention and control; research; and regulatory pathways for new products. The Action Plan outlines goals and actions that the participating federal agencies and departments are pursuing or planning to pursue in an effort to respond to the complex public health risk posed by antimicrobial resistance.

Following each of the goals listed for each focus area are several action items that define topic areas for specific projects or implementation steps. Wherever possible, action items are populated with specific projects or implementation steps to provide greater specificity for planned federal activities. The action items, projects and implementation steps do not represent an exhaustive list of activities. Project lists will be updated annually, and actions will be updated every two years.

Focus Area I: Surveillance, Prevention and Control of Antimicrobial Resistant Infections

Overarching Goal: In order to develop and implement effective control strategies there must be 1) continuous or periodic monitoring of infections caused by antimicrobial resistant (AR) microorganisms, 2) comprehensive knowledge of the use of antimicrobial agents across all sectors and 3) the capacity to develop, evaluate and implement effective prevention and containment strategies nationally and globally.

Focus Area II: Research

Overarching Goal: Encourage, conduct and support basic and translational research to enhance our understanding of factors leading to the development of AR microorganisms, their transmission in various settings and optimal modes of prevention, diagnosis and therapy.

Focus Area III: Regulatory Pathways for New Products

Overarching Goal: Encourage the development of products for bacterial disease to improve our capacity to diagnose, prevent and treat infections, including infections caused by resistant microorganisms.

Acronyms and Abbreviations
AHRQ Agency for Healthcare Research and Quality
APHL Association of Public Health Laboratories
AR Antimicrobial resistance
ASH Office of the Assistant Secretary for Health (HHS)
ASPE Office of the Assistant Secretary for Planning and Evaluation
ASPR Office of the Assistant Secretary for Preparedness and Response
BARDA Biomedical Advanced Research Development Authority (HHS)
CDC Centers for Disease Control and Prevention
CLSI Clinical and Laboratory Standards Institute
CMS Centers for Medicare and Medicaid Services
CSTE Council of State and Territorial Epidemiologists
DoD Department of Defense
EPA Environmental Protection Agency
FDA Food and Drug Administration
HAI Healthcare-associated infection
HAP Hospital-acquired pneumonia
HHS Department of Health and Human Services
HRSA Health Resources and Services Administration
IPEC Inpatient Evaluation Center
MDRO Multidrug-resistant organism
MRSA Methicillin-resistant Staphylococcus aureus
NHSN National Healthcare Safety Network
NIH National Institutes of Health
USDA United States Department of Agriculture
VA Department of Veterans Affairs
VAP Ventilator-associated pneumonia
VHA Veterans Health Administration
XDR TB Extensively drug-resistant tuberculosis

Top of Page

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #